×
About 9,340 results

ALLMedicine™ Aspergillosis Center

Research & Reviews  4,395 results

A physiologically based pharmacokinetic analysis to predict the pharmacokinetics of int...
https://doi.org/10.1128/AAC.02032-20
Antimicrobial Agents and Chemotherapy; Huang H, Xie H et. al.

Feb 23rd, 2021 - Isavuconazole (ISA) is an azole antifungal used in the treatment of invasive aspergillosis and mucormycosis. Patients with mild and moderate hepatic impairment have lower clearance (CL) as compared to the healthy population. Currently, there is no...

Aspergillus isolation in nontuberculous mycobacterial pulmonary disease: Associated wit...
https://doi.org/10.1016/j.rmed.2021.106338
Respiratory Medicine; Raats D, Aldhaheri SMS et. al.

Feb 21st, 2021 - Chronic pulmonary aspergillosis is a serious complication of nontuberculous mycobacterial pulmonary disease (NTM-PD), and diagnosis remains challenging. The present study examined associations between the respiratory isolation of Aspergillus and t...

Clinical characteristics and CT manifestations of invasive pulmonary aspergillosis in h...
https://doi.org/10.1016/j.crad.2021.01.006
Clinical Radiology; Suwatanapongched T, Visoottiviseth Y et. al.

Feb 21st, 2021 - To investigate clinical and computed tomography (CT) findings of invasive pulmonary aspergillosis (IPA) in patients with systemic lupus erythematosus (SLE) and to explore the relationships of CT findings with clinical characteristics and outcomes....

The Extend of Aspergillosis in Critically Ill Patients With Severe Influenza Pneumonia:...
https://doi.org/10.1097/CCM.0000000000004861
Critical Care Medicine; Coste A, Frérou A et. al.

Feb 16th, 2021 - To determine the frequency and prognosis of invasive pulmonary aspergillosis in critically ill patients with severe influenza pneumonia. Retrospective multicenter cohort study. Five French ICUs. Patients with influenza admitted to ICU between 2009...

Cerebral Invasive Aspergillosis in a Case of Chronic Lymphocytic Leukemia with Bruton T...
https://doi.org/10.3390/curroncol28010081
Current Oncology (Toronto, Ont.); Alkharabsheh O, Alsayed A et. al.

Feb 11th, 2021 - Bruton tyrosine kinase (BTK) inhibitors have become an important therapy for untreated and previously treated patients with chronic lymphocytic leukemia (CLL). Despite improved outcomes, rare adverse events, such as invasive fungal infections, hav...

see more →

Guidelines  17 results

Microbiological Laboratory Testing in the Diagnosis of Fungal Infections in Pulmonary a...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727169
American Journal of Respiratory and Critical Care Medicine; Hage CA, Carmona EM et. al.

Aug 30th, 2019 - Background: Fungal infections are of increasing incidence and importance in immunocompromised and immunocompetent patients. Timely diagnosis relies on appropriate use of laboratory testing in susceptible patients.Methods: The relevant literature r...

ESCMID-ECMM guideline: diagnosis and management of invasive aspergillosis in neonates a...
https://doi.org/10.1016/j.cmi.2019.05.019
Clinical Microbiology and Infection : the Official Public... Warris A, Lehrnbecher T et. al.

Jun 3rd, 2019 - Presenting symptoms, distributions and patterns of diseases and vulnerability to invasive aspergillosis (IA) are similar between children and adults. However, differences exist in the epidemiology and underlying conditions, the usefulness of newer...

Information for Healthcare Professionals about Aspergillosis
https://www.cdc.gov/fungal/diseases/aspergillosis/health-professionals.html

Dec 31st, 2018 - Information for healthcare professionals about aspergillosis. Aspergillosis is a disease caused by Aspergillus, a common mold (a type of fungus) that lives indoors and outdoors. Most people breathe in Aspergillus spores every day without getting s...

Individualized Medication of Voriconazole: A Practice Guideline of the Division of Ther...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250289
Therapeutic Drug Monitoring; Chen K, Zhang X et. al.

Sep 7th, 2018 - Voriconazole (VRZ) is a second-generation triazole antifungal agent with broad-spectrum activity. It is available in both intravenous and oral formulations, and is primarily indicated for treating invasive aspergillosis. The most commonly used dos...

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-...
https://doi.org/10.1016/j.cmi.2018.01.002
Clinical Microbiology and Infection : the Official Public... Ullmann AJ, Aguado JM et. al.

Mar 16th, 2018 - The European Society for Clinical Microbiology and Infectious Diseases, the European Confederation of Medical Mycology and the European Respiratory Society Joint Clinical Guidelines focus on diagnosis and management of aspergillosis. Of the numero...

see more →

Drugs  161 results see all →

Clinicaltrials.gov  4,641 results

A physiologically based pharmacokinetic analysis to predict the pharmacokinetics of int...
https://doi.org/10.1128/AAC.02032-20
Antimicrobial Agents and Chemotherapy; Huang H, Xie H et. al.

Feb 23rd, 2021 - Isavuconazole (ISA) is an azole antifungal used in the treatment of invasive aspergillosis and mucormycosis. Patients with mild and moderate hepatic impairment have lower clearance (CL) as compared to the healthy population. Currently, there is no...

Aspergillus isolation in nontuberculous mycobacterial pulmonary disease: Associated wit...
https://doi.org/10.1016/j.rmed.2021.106338
Respiratory Medicine; Raats D, Aldhaheri SMS et. al.

Feb 21st, 2021 - Chronic pulmonary aspergillosis is a serious complication of nontuberculous mycobacterial pulmonary disease (NTM-PD), and diagnosis remains challenging. The present study examined associations between the respiratory isolation of Aspergillus and t...

Clinical characteristics and CT manifestations of invasive pulmonary aspergillosis in h...
https://doi.org/10.1016/j.crad.2021.01.006
Clinical Radiology; Suwatanapongched T, Visoottiviseth Y et. al.

Feb 21st, 2021 - To investigate clinical and computed tomography (CT) findings of invasive pulmonary aspergillosis (IPA) in patients with systemic lupus erythematosus (SLE) and to explore the relationships of CT findings with clinical characteristics and outcomes....

The Extend of Aspergillosis in Critically Ill Patients With Severe Influenza Pneumonia:...
https://doi.org/10.1097/CCM.0000000000004861
Critical Care Medicine; Coste A, Frérou A et. al.

Feb 16th, 2021 - To determine the frequency and prognosis of invasive pulmonary aspergillosis in critically ill patients with severe influenza pneumonia. Retrospective multicenter cohort study. Five French ICUs. Patients with influenza admitted to ICU between 2009...

Voriconazole - voriconazole tablet-Cadila Healthcare Limited
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bda70104-d84b-4d3f-9ca0-5f4f1ca816ad

Feb 11th, 2021 - Voriconazole is an azole antifungal indicated for the treatment of adults and pediatric patients aged 12 to 14 years weighing greater than or equal to 50 kg and those aged 15 years and older regardless of body weight with: Invasive aspergillosis (...

see more →

News  117 results

Doctors Search for Missing Link Between COVID and ITP
https://www.medscape.com/viewarticle/944801

Jan 26th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Hospitalist Sarah Stone, MD, arrived for her dayshift at Sharp Chula Vista in California one day in late December. The ICU and hospital wards were...

The COVID Complication You Might Miss
https://www.medscape.com/viewarticle/940740_2

Nov 18th, 2020 - Question 1 of 2 What fungal infection is most likely in this patient? Your Peers Chose: Pneumocystis pneumonia 0% Aspergillosis 0% Mucormycosis 0% Phaeohyphomycosis 0% Question 2 of 2 What diagnostic tests should be done to evaluate for possible a...

Fatal Drug-Resistant Invasive Pulmonary Aspergillus fumigatus in a 56-Year-Old Immunosuppressed Man
https://www.mdedge.com/fedprac/article/171981/hematology/fatal-drug-resistant-invasive-pulmonary-aspergillus-fumigatus-56/page/0/2?channel=327

Aug 14th, 2019 - Conclusion This fatal case of invasive pulmonary aspergillosis illustrates the importance of considering the 4 main causes of treatment failure in an infection. Although the patient had a high burden of disease with a rare resistance pattern, he w.

Fast Five Quiz: How Much Do You Know About Asthma?
https://reference.medscape.com/viewarticle/846001_4

Jun 3rd, 2019 - Blood eosinophilia > 4% or 300-400 cells/μL supports the diagnosis of asthma, but the absence of this finding is not exclusionary. Total serum immunoglobulin E levels > 100 IU/mL are frequently observed in patients experiencing allergic reactions,...

Disseminated invasive aspergillosis in an immunocompetent patient
https://www.mdedge.com/ccjm/article/201706/infectious-diseases/disseminated-invasive-aspergillosis-immunocompetent-patient?channel=162
Jessica McLaughlin, DO, Eric Libre, MD, FCCP et. al.

Jun 3rd, 2019 - A 57-year-old woman was admitted to our hospital for progressive hypoxic respiratory failure that developed after 10 days of empiric treatment at another hospital for an exacerbation of chronic obstructive pulmonary disease (COPD). Figure 1.

see more →

Patient Education  9 results see all →